Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-17-011663
Filing Date
2017-11-09
Accepted
2017-11-09 16:02:25
Documents
69
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0917_myosrenstech.htm 10-Q 601125
2 CERTIFICATION f10q0917ex31-1_myosrens.htm EX-31.1 8438
3 CERTIFICATION f10q0917ex32-1_myosrens.htm EX-32.1 4211
  Complete submission text file 0001213900-17-011663.txt   4401622

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE myos-20170930.xml EX-101.INS 802428
5 XBRL SCHEMA FILE myos-20170930.xsd EX-101.SCH 47942
6 XBRL CALCULATION FILE myos-20170930_cal.xml EX-101.CAL 42485
7 XBRL DEFINITION FILE myos-20170930_def.xml EX-101.DEF 198796
8 XBRL LABEL FILE myos-20170930_lab.xml EX-101.LAB 458643
9 XBRL PRESENTATION FILE myos-20170930_pre.xml EX-101.PRE 326183
Mailing Address 45 HORSEHILL ROAD SUITE 106 CEDAR KNOLLS NJ 07927
Business Address 45 HORSEHILL ROAD SUITE 106 CEDAR KNOLLS NJ 07927 973-509-0444
MYOS RENS TECHNOLOGY INC. (Filer) CIK: 0001402479 (see all company filings)

EIN.: 900772394 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36533 | Film No.: 171190678
SIC: 2834 Pharmaceutical Preparations